True Wealth Design’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.16K Buy
220
+188
+588% +$5.29K ﹤0.01% 1251
2026
Q1
$913 Hold
32
﹤0.01% 1833
2025
Q4
$1.27K Sell
32
-26
-45% -$953 ﹤0.01% 1620
2025
Q3
$2.04K Buy
58
+11
+23% +$379 ﹤0.01% 1449
2025
Q2
$1.54K Sell
47
-5
-10% -$162 ﹤0.01% 1284
2025
Q1
$1.68K Hold
52
﹤0.01% 1071
2024
Q4
$1.59K Buy
52
+37
+247% +$1.19K ﹤0.01% 798
2024
Q3
$421 Buy
+15
New +$370 ﹤0.01% 1124

Other funds holding ATRC

True Wealth Design's ATRC Position: Q2 2026 in Review

True Wealth Design increased its AtriCure (ATRC) stake by 588% in Q2 2026, buying an estimated $5.29K and bringing the position to 220 shares worth $6.16K. The position accounts for ﹤0.01% of the portfolio, ranked #1251.

True Wealth Design first reported a position in ATRC in Q3 2024 and has held it in 8 quarters since. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • True Wealth Design held 220 shares of AtriCure worth $6.16K as of Q2 2026.
  • True Wealth Design bought 188 AtriCure shares in Q2 2026, an estimated $5.29K.
  • AtriCure made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1251 holding.
  • True Wealth Design first reported a position in AtriCure in Q3 2024 and has held it in 8 quarters since.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.